Improved intradialytic stability during haemodialysis with blood volume-controlled ultrafiltration.

Background: Intradialytic morbid events (IMEs) during haemodialysis (HD), including symptomatic hypotension, are related to ultrafiltration (UF)-induced hypovolaemia. Blood volume monitoring and automatic feedback control of the UF rate were developed to limit the extent of hypovolaemia during dialysis. The present study investigated the effect of blood volume (BV)-controlled UF on the incidence of HD treatments with IMEs.

[Mesenteric ischemia in hemodialyzed patients].

Objectives: Mesenteric ischemia is uncommon in the general population but is frequently encountered in chronic hemodialysis patients. We present here four cases which occurred in our unit within one year while only six cases had been observed in the preceding twenty years.

Observations: Four chronic hemodialysis patients (age: 57 to 76 years) with renal failure due to diffuse atheromatous disease, presented non-occlusive mesenteric ischemia.

[Ophthalmologic manifestations of dialysis. Retrospective study on 81 patients].

In this work, we looked at the results of a retrospective study carried out in our unit on the ocular manifestations in the dialysed chronic renal failure patient. Eighty-one of our 189 patients had an ophtalmic examination. Thirty-six showed a retinopathy, 26 suffered from a corneoconjunctival alterations, 19 from a cataract, 6 a vascular thrombosis, 4 a glaucoma and one motor-ocular paralysis.

[Twenty one years of hemodialysis in a patient with primary hyperoxaluria].

We report a male patient with primary hyperoxaluria from childhood who survived more than 21 years on conventional haemodialysis. Despite the severity of his bone disease, he was married and actively employed up until 2 years before his death. His condition really worsened a few months before his death.

[Aggravation of anemia in a hypertensive hemodialysis patient by captopril treatment].

We report here the case of an hypertensive chronic hemodialysis patient treated by captopril. Captopril treatment has been effective in normalizing blood pressure but induced a severe anemia necessitating frequent transfusions. Captopril withdrawal eliminated transfusion needs.